Pharmafile Logo
Pharmafocus logo
Advanced Search
celgene_building

Celgene and Acceleron’s blood disorder drug smashes endpoints at Phase 3

July 11, 2018
Research and Development Acceleron, Celgene, beta-thalassemia, luspatercept, pharma

Celgene and Acceleron have lifted the curtain on new Phase 3 data for their erythroid maturation agent (EMA) luspatercept, confirming …

News
westminster-parliament-resized

UK Government announces £10m antimicrobial resistance research competition

July 11, 2018
Research and Development 10 million, antimicrobial, competition, government, resistance

The UK Government’s Department of Health and Social Care has announced the launch of a £10 million research competition aimed …

News
28246711066_52e38bc591_z

EMA survey identifies gaps in pharma industry’s preparedness for Brexit

July 11, 2018
Research and Development CAPS, EEA, EMA, brexit, preparedness

An EMA survey has identified gaps in the pharmaceutical industry’s preparedness for Brexit, finding that only 58% of market authorisation …

News

Wellcome Trust announces £250m fund for high risk ideas

July 11, 2018
Research and Development 250 million, Wellcome, britain, leap fund, pharma

The London-based biomedical research charity the Wellcome Trust, Britain’s wealthiest foundation, has announced the launch of a new £250 million …

News
shutterstock_254160583

Trump forces Pfizer to back down and delay price hikes until 2019

July 11, 2018
Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma

Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …

News
mario_saltarelli_cropped

Syntimmune appoints Pfizer, AbbVie veteran as new CMO

July 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, John Hopkins University, Pfizer, Syntimmune

The Boston-based clinical biotechnology company Syntimmune has appointed Dr Mario Saltarelli as its Chief Medical Officer. Dr Saltarelli will take …

Appointment
india_china_credit_pti

China opens market to Indian drugs with reduced tariffs

July 10, 2018
Manufacturing and Production, Sales and Marketing China, India, pharma

India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …

News
shutterstock_2

EMA issues global recall of heart drugs over cancer risk contamination

July 10, 2018
Manufacturing and Production EMA, Europe, heart disease, pharma, valsartan

Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …

News
sanofihq

Sanofi shut down French plant over “astronomical” emission levels

July 10, 2018
Manufacturing and Production FNE, France, Sanofi, manufacturing, pharma, valproate

Sanofi announced yesterday that they have stopped production at their plant in the French Pyrenees following complaints that the factory …

News

NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears

July 10, 2018
Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …

News
donald_trump_september_3_2015

Trump slams Pfizer over price hikes, Pfizer responds

July 10, 2018
Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, Pfizer, Trump, pharma

Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks …

News
merckincweb2

MSD’s ulcerative colitis drug scores expanded indication in Europe

July 9, 2018
Sales and Marketing Europe, MSD, pharma, ulcerative colitis

New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in …

News

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 9, 2018
Research and Development, Sales and Marketing

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …

News
shutterstock_212035546

Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk

July 9, 2018
Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …

News

Insider Interview: Biosimilars to balance the books

July 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …

Feature

Scotland approves first-line treatment for advanced kidney cancer

July 9, 2018
Sales and Marketing Cancer, Scotland, fotivda, rcc, tivozanib

The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with …

News
shutterstock_114045100

Regulus cuts workforce by 60%, halts studies in major restructure

July 9, 2018
Sales and Marketing Regulus, pharma

California-based biotech Regulus Therapeutics has announced it is to strip away more than half of its total workforce as part …

News
sicorbio

Teva to relocate US HQ to New Jersey, affecting over 1,000 jobs

July 6, 2018
Manufacturing and Production, Medical Communications Teva, US, new jersey, pharma, philadelphia

As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Astrazenaca, Donald Trump, Pfizer, pharma, top ten

As the first week of July comes to an end we take a look over the most popular stories of …

News
michel_porro-getty_images

Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018
Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026